Guoke Hengtai released its 2026 interim report, showing first-half net profit attributable to the parent of 10.71 million yuan, down 79.4% year on year. Operating revenue was 3.164 billion yuan, down 14.0% year on year. Net profit attributable to the parent after deducting non-recurring items was 990,000 yuan, down 97.9% year on year. Net operating cash flow was 302 million yuan, down 22.0% year on year. Earnings per share were 0.02 yuan. In the second quarter, operating revenue was 1.6 billion yuan, down 17.7% year on year, and net profit attributable to the parent was 9.46 million yuan, down 84.5% year on year. As of the end of the second quarter, total assets were 6.257 billion yuan, down 1.3% from the end of the previous year, and net assets attributable to the parent were 2.461 billion yuan, down 1.8% from the end of the previous year. The company said the decline was mainly affected by industry policy, market demand and the macroeconomic environment. The overall market size of the medical device distribution industry fell 12.78% year on year in the first half, and the company continued to implement its product structure adjustment strategy, proactively exiting some product lines with weaker profitability.
GKHT Medical Technology Co. Ltd. AFirst-half net profit attributable to parent fell 79.4% to 10.71 million yuan, with revenue down 14.0%.
